These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10677589)

  • 61. Inhibition of glycosphingolipid synthesis by threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) and the modulation of IL-1beta-stimulated expression of inducible nitric oxide synthase in rat aortic smooth muscle cells.
    Weber AA; Seul C; Harth V; Ko Y; Seewald S; Vetter H; Sachinidis A
    Br J Pharmacol; 1998 Mar; 123(5):906-10. PubMed ID: 9535019
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antisense oligodeoxynucleotide to inducible nitric oxide synthase inhibits nitric oxide synthesis in rat pulmonary artery smooth muscle cells in culture.
    Thomae KR; Geller DA; Billiar TR; Davies P; Pitt BR; Simmons RL; Nakayama DK
    Surgery; 1993 Aug; 114(2):272-7. PubMed ID: 7688152
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antioxidant enzymes suppress nitric oxide production through the inhibition of NF-kappa B activation: role of H(2)O(2) and nitric oxide in inducible nitric oxide synthase expression in macrophages.
    Han YJ; Kwon YG; Chung HT; Lee SK; Simmons RL; Billiar TR; Kim YM
    Nitric Oxide; 2001; 5(5):504-13. PubMed ID: 11587565
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ginsenoside Rg3 inhibits phenylephrine-induced vascular contraction through induction of nitric oxide synthase.
    Kim ND; Kim EM; Kang KW; Cho MK; Choi SY; Kim SG
    Br J Pharmacol; 2003 Oct; 140(4):661-70. PubMed ID: 14534150
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nitric oxide inhibits inducible nitric oxide synthase mRNA expression in RAW 264.7 macrophages.
    Hinz B; Brune K; Pahl A
    Biochem Biophys Res Commun; 2000 May; 271(2):353-7. PubMed ID: 10799301
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Adventitia as a source of inducible nitric oxide synthase in the rat aorta.
    Zhang H; Du Y; Cohen RA; Chobanian AV; Brecher P
    Am J Hypertens; 1999 May; 12(5):467-75. PubMed ID: 10342784
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Apolipoprotein E inhibition of vascular smooth muscle cell proliferation but not the inhibition of migration is mediated through activation of inducible nitric oxide synthase.
    Ishigami M; Swertfeger DK; Hui MS; Granholm NA; Hui DY
    Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1020-6. PubMed ID: 10764667
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Upregulation of iNOS Protects Cyclic Mechanical Stretch-Induced Cell Death in Rat Aorta Smooth Muscle Cells.
    Zhao J; Nakahira K; Kimura A; Kyotani Y; Yoshizumi M
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212839
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Felodipine inhibits free-radical production by cytokines and glucose in human smooth muscle cells.
    Hishikawa K; Lüscher TF
    Hypertension; 1998 Dec; 32(6):1011-5. PubMed ID: 9856965
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibition of nitric oxide synthase by antineoplastic anthracyclines.
    Luo D; Vincent SR
    Biochem Pharmacol; 1994 Jun; 47(11):2111-2. PubMed ID: 7516659
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Characterization of cell selectivity of two novel inhibitors of nitric oxide synthesis.
    Lambert LE; French JF; Whitten JP; Baron BM; McDonald IA
    Eur J Pharmacol; 1992 May; 216(1):131-4. PubMed ID: 1382020
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In vitro induction of nitric oxide by fructose-1,6-diphosphate in the cardiovascular system of rats.
    Rao MR; Olinde KD; Markov AK
    Mol Cell Biochem; 1998 Aug; 185(1-2):171-5. PubMed ID: 9746223
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Minimal amidine structure for inhibition of nitric oxide biosynthesis.
    Billack B; Heck DE; Porterfield DM; Malchow RP; Smith PJ; Gardner CR; Laskin DL; Laskin JD
    Biochem Pharmacol; 2001 Jun; 61(12):1581-6. PubMed ID: 11377388
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Anticancer drugs inhibit induction of NO synthase in rat in vivo.
    Inagaki R; Taniguchi T; Sakai T; Hayashi N; Ishii Y; Muramatsu I
    Gen Pharmacol; 1999 Feb; 32(2):185-8. PubMed ID: 10188617
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Enhanced production of interleukin 1 by mouse peritoneal macrophages after aclacinomycin administration.
    Bravo-Cuellar A; Martin-Ruiz JL; Liu XH; Orbach-Arbouys S
    Immunol Lett; 1990 Jan; 23(3):165-72. PubMed ID: 2307488
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Vascular actions of anthracycline antibiotics.
    Wakabayashi I; Groschner K
    Curr Med Chem; 2003 Mar; 10(5):427-36. PubMed ID: 12570699
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Selective distribution of aclarubicin to regional lymph nodes with a new dosage form: aclarubicin adsorbed on activated carbon particles.
    Hagiwara A; Takahashi T; Iwamoto A; Yoneyama C; Matsumoto S; Muranishi S
    Anticancer Drugs; 1991 Jun; 2(3):261-6. PubMed ID: 1802020
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Therapeutics: turnover.
    McCarthy N
    Nat Rev Cancer; 2013 Jun; 13(6):380-1. PubMed ID: 23615693
    [No Abstract]   [Full Text] [Related]  

  • 79. R59949, a diacylglycerol kinase inhibitor, inhibits inducible nitric oxide production through decreasing transplasmalemmal L-arginine uptake in vascular smooth muscle cells.
    Shimomura T; Nakano T; Goto K; Wakabayashi I
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):207-214. PubMed ID: 27909743
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inhibitory effects of aclarubicin on nitric oxide production in aortic smooth muscle cells and macrophages.
    Wakabayashi I; Mayer B; Groschner K
    Biochem Pharmacol; 2000 Mar; 59(6):719-26. PubMed ID: 10677589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.